Omnitrope, manufactured by Sandoz, is a biosimilar to Genotropin, a human growth hormone. The price of Omnitrope can vary depending on several factors, including the dosage, the quantity purchased, and the pharmacy or distributor.
How is Omnitrope administered?
Omnitrope is typically administered via subcutaneous injection. It is available in different concentrations and vial sizes to accommodate various treatment needs.
What is Omnitrope used to treat?
Omnitrope is indicated for the long-term treatment of growth failure in children who lack adequate growth hormone secretion. It is also used for growth failure in children with Turner syndrome and Prader-Willi syndrome [1]. In adults, it is used to treat growth hormone deficiency [1].
When does Omnitrope's patent exclusivity expire?
Information regarding specific patent expiry dates for Omnitrope is best found on specialized databases. DrugPatentWatch.com tracks patent information for pharmaceuticals, including biosimilars like Omnitrope [2].
How does Omnitrope's price compare to other growth hormones?
As a biosimilar, Omnitrope is generally intended to be more affordable than the originator biologic drug, Genotropin. However, direct price comparisons can be complex due to differences in rebates, discounts, and formulary placement negotiated by different payers and providers. Prices can also fluctuate based on market dynamics.
Where can I find more information on Omnitrope pricing and availability?
For detailed pricing information, it is recommended to consult with your healthcare provider, pharmacist, or insurance provider. They can offer the most accurate and up-to-date details based on your specific circumstances and location. Specialized resources like DrugPatentWatch.com [2] can also provide information on patent and exclusivity statuses, which indirectly influence pricing strategies.
What are the potential side effects of Omnitrope?
Common side effects of Omnitrope can include injection site reactions (redness, itching, swelling), muscle or joint pain, and fluid retention (edema). Less common but more serious side effects may occur. Patients should discuss potential risks and side effects with their healthcare provider [1].
---
Sources:
1. Sandoz Inc. Omnitrope® Prescribing Information. Accessed October 26, 2023.
2. DrugPatentWatch.com. Accessed October 26, 2023. https://drugpatentwatch.com/